No Data
No Data
GEHC Stock Gains on Long-Term Collaboration With Sutter Health
A Quick Look at Today's Ratings for Masimo(MASI.US), With a Forecast Between $178 to $193
Masimo's Strong Performance and Promising Outlook: Buy Rating Affirmed
Express News | Needham Reiterates Hold on Masimoto Hold
Needham Sticks to Their Hold Rating for Masimo (MASI)
Masimo Announces Preliminary Q4 2024 Revenue At $601M, Up 9%; Healthcare Revenue At $368M, Up 8%; FY24 Revenue At $2.094B, Up 2%; Healthcare Revenue At $1.395B, Up 9%; Non-GAAP EPS Exceeds $4.10; FY25 Guidance Includes Healthcare Revenue Growth Up To...